Global Pharmaceutical Analytical Testing 麻豆原创 Research Report 2025

Publication ID:

PB503252884

Publication Date:

March 11, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Pharmaceutical Analytical Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharmaceutical Analytical Testing refers to the scientific process of evaluating pharmaceutical products and raw materials to ensure their quality, safety, and efficacy. It involves a range of tests and techniques that measure and analyze the chemical composition, physical properties, and biological activity of pharmaceutical substances. These tests are conducted in compliance with regulatory standards to verify the identity, purity, strength, and stability of drugs and ensure they meet the required specifications before being released to the market. Pharmaceutical analytical testing plays a crucial role in maintaining the integrity and effectiveness of pharmaceutical products throughout their lifecycle.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Analytical Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Analytical Testing.
The Pharmaceutical Analytical Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Analytical Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Analytical Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Laboratory Testing
Eurofins Scientific
SGS SA
Intertek Phamaceutical Services
West Pharmaceutical Services
Toxikon
Pace Analytical Services
Boston Analytical
Steris
Catalent
Charles River Laboratories
Merck
Solvias
Segment by Type
Bioanalytical Testing
Method Development & Validation
Stability Testing
Drug Substances Testing
Segment by Application
Laboratory and Research Institutions
Pharmaceutical Center
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Analytical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Pharmaceutical Analytical Testing 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bioanalytical Testing
1.2.3 Method Development & Validation
1.2.4 Stability Testing
1.2.5 Drug Substances Testing
1.3 麻豆原创 by Application
1.3.1 Global Pharmaceutical Analytical Testing 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory and Research Institutions
1.3.3 Pharmaceutical Center
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Analytical Testing 麻豆原创 Perspective (2020-2031)
2.2 Global Pharmaceutical Analytical Testing Growth Trends by Region
2.2.1 Global Pharmaceutical Analytical Testing 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Analytical Testing Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Pharmaceutical Analytical Testing Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Pharmaceutical Analytical Testing 麻豆原创 Dynamics
2.3.1 Pharmaceutical Analytical Testing Industry Trends
2.3.2 Pharmaceutical Analytical Testing 麻豆原创 Drivers
2.3.3 Pharmaceutical Analytical Testing 麻豆原创 Challenges
2.3.4 Pharmaceutical Analytical Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Analytical Testing Players by Revenue
3.1.1 Global Top Pharmaceutical Analytical Testing Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Analytical Testing Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Pharmaceutical Analytical Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Analytical Testing Revenue
3.4 Global Pharmaceutical Analytical Testing 麻豆原创 Concentration Ratio
3.4.1 Global Pharmaceutical Analytical Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Analytical Testing Revenue in 2024
3.5 Global Key Players of Pharmaceutical Analytical Testing Head office and Area Served
3.6 Global Key Players of Pharmaceutical Analytical Testing, Product and Application
3.7 Global Key Players of Pharmaceutical Analytical Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Analytical Testing Breakdown Data by Type
4.1 Global Pharmaceutical Analytical Testing Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Pharmaceutical Analytical Testing Forecasted 麻豆原创 Size by Type (2026-2031)
5 Pharmaceutical Analytical Testing Breakdown Data by Application
5.1 Global Pharmaceutical Analytical Testing Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Pharmaceutical Analytical Testing Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Analytical Testing 麻豆原创 Size (2020-2031)
6.2 North America Pharmaceutical Analytical Testing 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2020-2025)
6.4 North America Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Analytical Testing 麻豆原创 Size (2020-2031)
7.2 Europe Pharmaceutical Analytical Testing 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2020-2025)
7.4 Europe Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Analytical Testing 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Analytical Testing 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Analytical Testing 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Analytical Testing 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Analytical Testing 麻豆原创 Size (2020-2031)
9.2 Latin America Pharmaceutical Analytical Testing 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Analytical Testing 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Analytical Testing 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Analytical Testing 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Laboratory Testing
11.1.1 Laboratory Testing Company Details
11.1.2 Laboratory Testing Business Overview
11.1.3 Laboratory Testing Pharmaceutical Analytical Testing Introduction
11.1.4 Laboratory Testing Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.1.5 Laboratory Testing Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Pharmaceutical Analytical Testing Introduction
11.2.4 Eurofins Scientific Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 SGS SA
11.3.1 SGS SA Company Details
11.3.2 SGS SA Business Overview
11.3.3 SGS SA Pharmaceutical Analytical Testing Introduction
11.3.4 SGS SA Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.3.5 SGS SA Recent Development
11.4 Intertek Phamaceutical Services
11.4.1 Intertek Phamaceutical Services Company Details
11.4.2 Intertek Phamaceutical Services Business Overview
11.4.3 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Introduction
11.4.4 Intertek Phamaceutical Services Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.4.5 Intertek Phamaceutical Services Recent Development
11.5 West Pharmaceutical Services
11.5.1 West Pharmaceutical Services Company Details
11.5.2 West Pharmaceutical Services Business Overview
11.5.3 West Pharmaceutical Services Pharmaceutical Analytical Testing Introduction
11.5.4 West Pharmaceutical Services Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.5.5 West Pharmaceutical Services Recent Development
11.6 Toxikon
11.6.1 Toxikon Company Details
11.6.2 Toxikon Business Overview
11.6.3 Toxikon Pharmaceutical Analytical Testing Introduction
11.6.4 Toxikon Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.6.5 Toxikon Recent Development
11.7 Pace Analytical Services
11.7.1 Pace Analytical Services Company Details
11.7.2 Pace Analytical Services Business Overview
11.7.3 Pace Analytical Services Pharmaceutical Analytical Testing Introduction
11.7.4 Pace Analytical Services Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.7.5 Pace Analytical Services Recent Development
11.8 Boston Analytical
11.8.1 Boston Analytical Company Details
11.8.2 Boston Analytical Business Overview
11.8.3 Boston Analytical Pharmaceutical Analytical Testing Introduction
11.8.4 Boston Analytical Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.8.5 Boston Analytical Recent Development
11.9 Steris
11.9.1 Steris Company Details
11.9.2 Steris Business Overview
11.9.3 Steris Pharmaceutical Analytical Testing Introduction
11.9.4 Steris Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.9.5 Steris Recent Development
11.10 Catalent
11.10.1 Catalent Company Details
11.10.2 Catalent Business Overview
11.10.3 Catalent Pharmaceutical Analytical Testing Introduction
11.10.4 Catalent Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.10.5 Catalent Recent Development
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Company Details
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Pharmaceutical Analytical Testing Introduction
11.11.4 Charles River Laboratories Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.11.5 Charles River Laboratories Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Pharmaceutical Analytical Testing Introduction
11.12.4 Merck Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Solvias
11.13.1 Solvias Company Details
11.13.2 Solvias Business Overview
11.13.3 Solvias Pharmaceutical Analytical Testing Introduction
11.13.4 Solvias Revenue in Pharmaceutical Analytical Testing Business (2020-2025)
11.13.5 Solvias Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Laboratory Testing
Eurofins Scientific
SGS SA
Intertek Phamaceutical Services
West Pharmaceutical Services
Toxikon
Pace Analytical Services
Boston Analytical
Steris
Catalent
Charles River Laboratories
Merck
Solvias

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.